China Resources Sanjiu and Yumi Tech Announce Strategic Partnership to Build a Data-Driven Integrated Platform for Chronic Disease Management

Recently, China Resources Sanjiu and Yuemi Technology jointly announced a strategic partnership to co-develop a data-driven integrated management platform for chronic disease patients and physicians, focusing on areas such as pediatric growth and development. The platform will cover multiple core scenarios, including physician education, doctor-patient interaction, patient management, internet hospitals, and DTP (Direct-to-Patient) pharmacies, aiming to serve China’s vast population of chronic disease patients. In addition to establishing a data-driven online closed-loop system for doctor-patient management, this collaboration will leverage Yuemi Technology’s offline resources to further integrate online and offline service delivery, thereby enhancing the end-to-end patient service experience.

Driven by the growing health demands of Chinese residents and the deepening aging of society, market demand for chronic disease management services has been continuously increasing, leading to rapid development in the online chronic disease management sector. According to the “Blue Book on China’s Internet Chronic Disease Management Industry” released by CIC Consulting, the market size of China’s online chronic disease management industry, measured by gross merchandise value (GMV), increased from RMB 27.6 billion in 2015 to RMB 103.4 billion in 2021, representing a compound annual growth rate (CAGR) of 24.6%. It is projected to reach RMB 1,131.2 billion by 2030, with an expected CAGR of 30.5%.

Chronic disease management has its unique characteristics, often requiring integration with the patient’s needs for “long-term duration, high frequency, and intensive management,” as well as more convenient multi-directional communication and management tools. China Resources Sanjiu and Yuemi Technology have jointly built a data-driven integrated doctor-patient platform. Based on the WeChat and WeCom ecosystems, this platform establishes functional systems for four key roles—patient management, physician management, customer service management, and sales management—providing tailored functionalities to each role and enabling multidimensional connectivity and engagement. Furthermore, by leveraging Yuemi’s extensive upstream and downstream supply chain resources, the partners will develop a comprehensive online digital marketing platform.

Project Lead, China Resources SanjiuIt stated: “The Report on the Nutrition and Chronic Disease Status of Chinese Residents shows that in 2019, deaths attributable to chronic diseases accounted for 88.5% of total deaths in China, indicating a vast user base for chronic disease management. Driven by both market demand and policy guidance, and further accelerated by the impact of the pandemic, the field of chronic disease management has experienced rapid development. Adhering to its corporate mission of ‘Caring for Public Health, Co-creating a Better Life,’ China Resources Sanjiu has established a long-term strategy and comprehensive layout in chronic disease management. By jointly building a data-driven integrated doctor-patient platform with Yuemi Technology, the company focuses on promoting healthy development in multiple chronic disease areas, including child growth and development. Leveraging convenient internet technologies and professional medical health services, it aims to provide more efficient and scientific health protection for the broad population of patients with chronic diseases.”

Qiao Minghui, CEO of Yuemi TechnologyHe stated, “The rapid development of online chronic disease management is an inevitable trend driven by market demand, policy incentives, and the broader environment. Meanwhile, we have observed that traditional chronic disease management models suffer from urgent pain points such as resource constraints, low efficiency, and passive service delivery. To address these limiting factors, Yuemi Technology has prescribed an effective ‘remedy’—a data-driven, integrated physician-patient service model. Over the past five years, Yuemi Technology has achieved end-to-end implementation experience, starting from scratch, in fields including immune-mediated diseases, dermatology, the ‘three highs’ (hypertension, hyperglycemia, and hyperlipidemia), pediatric growth and development, and oncology. Through this collaboration, we aim to closely integrate Yuemi Technology’s integrated physician-patient service system with China Resources Sanjiu’s core competencies, providing patients with comprehensive, end-to-end health solutions. By harnessing the power of digitalization and technology, we are committed to contributing our share to the health management and future well-being of chronic disease patients in China.”

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (hereinafter referred to as “CR Sanjiu”) is a large state-controlled listed pharmaceutical company primarily engaged in the research and development, production, and sales of pharmaceutical products, as well as related health services. Since its listing, the company has been repeatedly recognized as one of the “Top 100 Golden Bull” and “Top 100 Value” enterprises among companies listed on China’s main board. To date, CR Sanjiu has been included in the Shenzhen Component Index, the CSI 500 Index, the MSCI Emerging Markets Index, and the FTSE Russell Index.

Yuemi Technology: A Provider of Data-Driven Integrated Solutions for Pharmaceutical Marketing. Continuously focusing on the digitalization of pharmaceutical marketing, Yuemi Technology empowers the digital transformation of pharmaceutical and medical device enterprises by offering SaaS-based products—such as private-domain platforms for doctors and patients, integrated doctor-patient services, data middle platforms for pharmaceutical marketing, and business middle platforms for pharmaceutical marketing—as well as specialized services including sales conversion optimization, physician insights, and medical knowledge graphs.